Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein.

McAuley, Alexander J; Kuiper, Michael J; Durr, Peter A; Bruce, Matthew P; Barr, Jennifer; Todd, Shawn; Au, Gough G; Blasdell, Kim; Tachedjian, Mary; Lowther, Sue; Marsh, Glenn A; Edwards, Sarah; Poole, Timothy; Layton, Rachel; Riddell, Sarah-Jane; Drew, Trevor W; Druce, Julian D; Smith, Trevor R F; Broderick, Kate E; Vasan, S S

McAuley, Alexander J; Kuiper, Michael J; Durr, Peter A; Bruce, Matthew P; Barr, Jennifer; Todd, Shawn; Au, Gough G; Blasdell, Kim; Tachedjian, Mary; Lowther, Sue; Marsh, Glenn A; Edwards, Sarah; Poole, Timothy; Layton, Rachel; Riddell, Sarah-Jane; Drew, Trevor W; Druce, Julian D; Smith, Trevor R F; Broderick, Kate E; Vasan, S S.

Afiliación

McAuley AJ; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Kuiper MJ; Commonwealth Scientific and Industrial Research Organisation, Data61, Docklands, VIC 3008 Australia.
Durr PA; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Bruce MP; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Barr J; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Todd S; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Au GG; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Blasdell K; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Tachedjian M; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Lowther S; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Marsh GA; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Edwards S; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Poole T; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Layton R; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Riddell SJ; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Drew TW; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.
Druce JD; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia.
Smith TRF; Inovio Pharmaceuticals, 10480 Wateridge Circle, San Diego, CA 92121 USA.
Broderick KE; Inovio Pharmaceuticals, 10480 Wateridge Circle, San Diego, CA 92121 USA.
Vasan SS; Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC 3219 Australia.

NPJ Vaccines ; 5: 96, 2020.

Article en En | MEDLINE | ID: mdl-33083031

Palabras clave

SARS-CoV-2; Vaccines; Viral evolution

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2020 Tipo del documento: Article